MONDAY, Feb. 12, 2024 (HealthDay News) — Novo Nordisk has settled lawsuits against two Florida businesses that claimed to sell copycat versions of its popular weight-loss drugs Ozempic and Wegovy. The Danish drugmaker announced the settlements Friday, according to NBC News.  The move capped a legal battle that began inContinue Reading

MONDAY, Feb. 12, 2024 (HealthDay News) — Don’t expect to sweat away the heart risks posed by sugary sodas and drinks, a new study warns. Canadian researchers found that even if the recommended 150 minutes of weekly physical activity protects against cardiovascular disease, it’s not enough to counter the adverseContinue Reading

MONDAY, Feb. 5, 2024 (HealthDay News) — The weight-loss drug Zepbound provides more health benefits than dropping pounds and controlling diabetes, a new study shows. It also appears to help people with obesity manage their high blood pressure, results show. Patients taking Zepbound (tirzepatide) experienced a significant reduction in theirContinue Reading

FRIDAY, Jan. 12, 2024 (HealthDay News) — Drugs like Wegovy and Ozempic, which have become a wildly popular way to lose weight or battle diabetes, show no link to suicidal thoughts or actions, the U.S. Food and Drug Administration said Thursday. “Our preliminary evaluation has not found evidence that useContinue Reading